These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3942005)

  • 21. Evidence for the presence of 2-(o-cresyl)-4H-1:3:2-benzodioxaphosphoran-2-one in cat intestine following tri-o-cresyl phosphate administration.
    Taylor JD; Buttar HS
    Toxicol Appl Pharmacol; 1967 Nov; 11(3):529-37. PubMed ID: 4296867
    [No Abstract]   [Full Text] [Related]  

  • 22. Testicular toxicity following oral administration of tri-o-cresyl phosphate (TOCP) in roosters.
    Somkuti SG; Lapadula DM; Chapin RE; Lamb JC; Abou-Donia MB
    Toxicol Lett; 1987 Aug; 37(3):279-90. PubMed ID: 3617103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Healthy F-16 pilots show no evidence of exposure to tri-ortho-cresyl phosphate through the on-board oxygen generating system.
    Tacal O; Schopfer LM
    Chem Biol Interact; 2014 May; 215():69-74. PubMed ID: 24661946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroxylation and cyclization reactions involved in the metabolism of tri-o-cresyl phosphate.
    ETO M; CASIDA JE; ETO T
    Biochem Pharmacol; 1962; 11():337-52. PubMed ID: 13890904
    [No Abstract]   [Full Text] [Related]  

  • 25. Detection of cresyl phosphate-modified butyrylcholinesterase in human plasma for chemical exposure associated with aerotoxic syndrome.
    Schopfer LM; Masson P; Lamourette P; Simon S; Lockridge O
    Anal Biochem; 2014 Sep; 461():17-26. PubMed ID: 24892986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of ortho-cresyl phosphate isomers of tricresyl phosphate used in aircraft turbine engine oils by gas chromatography and mass spectrometry.
    De Nola G; Kibby J; Mazurek W
    J Chromatogr A; 2008 Jul; 1200(2):211-6. PubMed ID: 18550071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reproductive tract lesions resulting from subchronic administration (63 days) of tri-o-cresyl phosphate in male rats.
    Somkuti SG; Lapadula DM; Chapin RE; Lamb JC; Abou-Donia MB
    Toxicol Appl Pharmacol; 1987 Jun; 89(1):49-63. PubMed ID: 3590188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analytical and preparative chromatographic procedures for obtaining pure cresyl violet and cresyl red from commercial cresyl violet.
    Urrutia MN; Ortiz CS
    Biotech Histochem; 2015 Apr; 90(3):159-66. PubMed ID: 25358291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxicokinetics of [14C]-saligenin cyclic-o-tolyl phosphate in anesthetized male F-344 rats.
    Burka LT; Chapin RE
    Reprod Toxicol; 1993; 7(1):81-6. PubMed ID: 8448420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variation between three strains of rat: inhibition of neurotoxic esterase and acetylcholinesterase by tri-o-cresyl phosphate.
    Carrington CD; Abou-Donia MB
    J Toxicol Environ Health; 1988; 25(3):259-68. PubMed ID: 3184197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of delayed neurotoxicity in the mouse following chronic oral administration of tri-o-cresyl phosphate.
    Lapadula DM; Patton SE; Campbell GA; Abou-Donia MB
    Toxicol Appl Pharmacol; 1985 Jun; 79(1):83-90. PubMed ID: 4049409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Inhibitory activities of tri-ortho-cresyl phosphate (TOCP) against cholinesterase and neurotoxic esterase].
    Kawai M; Iyatomi A; Kaneko Y
    Sangyo Igaku; 1984 Jan; 26(1):68-9. PubMed ID: 6482069
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of tri-o-cresyl phosphate, tri-o-cresyl thiophosphate and 2-(o-cresyl)-4H :1:3:2 benzodioxaphosphoran-2-one on pentobarbital induced sleeping time in mice.
    Buttar HS; Tyrrell DL; Taylor JD
    Arch Int Pharmacodyn Ther; 1968 Apr; 172(2):373-9. PubMed ID: 5684249
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of the functional effects of dyflos, tri-o-cresyl phosphate and tri-p-ethylphenyl phosphate in chickens.
    CAVANAGH JB; DAVIES DR; HOLLAND P; LANCASTER M
    Br J Pharmacol Chemother; 1961 Aug; 17(1):21-7. PubMed ID: 13691738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The time course of protection from delayed neurotoxicity induced by tri-o-cresyl phosphate and O,O-diisopropyl phosphorofluoridate by phenyl methyl sulfonyl fluoride in chickens.
    Carrington CD; Abou-Donia MB
    Toxicol Lett; 1983 Sep; 18(3):251-6. PubMed ID: 6665797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA adduct formation in Salmonella typhimurium, cultured liver cells and in Fischer 344 rats treated with o-tolyl phosphates and their metabolites.
    Mentzschel A; Vamvakas S; Dekant W; Henschler D
    Carcinogenesis; 1993 Oct; 14(10):2039-43. PubMed ID: 8222051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percutaneous toxicity and delayed neurotoxicity of organophosphates in the scaleless hen.
    Cisson CM; Wilson BW
    Toxicol Appl Pharmacol; 1983 Mar; 67(3):310-21. PubMed ID: 6845361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurologic manifestations of tri-O-cresyl phosphate delayed neurotoxicity in cats.
    Abou-Donia MB; Jensen DN; Lapadula DM
    Neurobehav Toxicol Teratol; 1983; 5(4):431-42. PubMed ID: 6646317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of metabolic inhibition with piperonyl butoxide on rodent sensitivity to tri-ortho-cresyl phosphate.
    Veronesi B
    Exp Neurol; 1984 Sep; 85(3):651-60. PubMed ID: 6088273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impairment of glutamate signaling in mouse central nervous system neurons in vitro by tri-ortho-cresyl phosphate at noncytotoxic concentrations.
    Hausherr V; van Thriel C; Krug A; Leist M; Schöbel N
    Toxicol Sci; 2014 Nov; 142(1):274-84. PubMed ID: 25199799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.